62 results on '"Drayson M"'
Search Results
2. T043 Exent mass spectrometry allows early identification of multiclonal MGUS compared to electrophoretic methods
3. Establishing the prevalence of common, clinically relevant tissue-specific autoantibodies following SARS CoV-2 infection
4. Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients
5. Dissecting racial disparities in multiple myeloma—clues from differential immunoglobulin levels
6. S873 EFFICACY OF QUADRUPLET KCRD (CARFILZOMIB, CYCLOPHOSPHAMIDE, LENALIDOMIDE AND DEXAMETHASONE) INDUCTION FOR NEWLY DIAGNOSED MYELOMA PATIENTS: ANALYSIS OF THE MYELOMA XI STUDY BY MOLECULAR RISK
7. The Impact of Respiratory Illness on the Morbidity and Mortality in Non-Small Cell Lung Cancer: A Single-Centre Retrospective Analysis
8. Monocyte activation and cytokine production in Malawian children presenting with P. falciparum malaria
9. Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen
10. High versus attenuated dose dexamethasone has little effect on the speed or depth of response to induction therapy for myeloma
11. Renal Function and Age at Presentation and Serum Free Light Chain Response at Post-induction Predict Renal Outcome
12. Presentation free light chain levels and age are the strongest predictors of renal function in newly diagnosed multiple myeloma patients
13. Progression-Free Survival Following Autologous Transplantation for Multiple Myeloma is Not Compromised by the Use of Dose-Adjusted Melphalan
14. The quadruplet KCRD (carfilzomib, cyclophosphamide, lenalidomide, and dexamethasone) is safe and well tolerated as induction therapy for newly diagnosed, transplant eligible, myeloma patients
15. Serum Free Light Chain Assays, not Total Light Chain Assays, are the Standard of Care in the Assessment of Monoclonal Gammopathies
16. The Impact of Dialysis-Dependent Acute Kidney Injury on Mortality in Myeloma: Findings from England Hospital Episode Statistics Data
17. Guidelines for the correct determination of second primary malignancies in myeloma trials
18. Metabolic plasticity in CLL: adaptation to the hypoxic niche
19. A Comparison Between Antigen-Laden Cells and Dendritic Cells in Afferent and Efferent Lymph
20. A Novel Histone Deacetylase-6 Inhibitior Reveals a Potent Immunosuppressant
21. Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
22. Infection risk in ANCA-associated vasculitis
23. Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
24. Does zoledronic acid (ZOL) reduce skeletal-related events (SREs) and improve progression-free survival (PFS) in patients (Pts) with multiple myeloma (MM) with or without bone disease? MRC myeloma IX study results.
25. Are there benefits to long-term bisphosphonate treatment in multiple myeloma (MM)? Insights from temporal analyses of zoledronic acid (ZOL) versus clodronate (CLO) in the MRC Myeloma IX Trial.
26. Defining the biological subgroup of multiple myeloma patients which benefits maximally from the overall survival (OS) benefit associated with treatment with zoledronic acid (ZOL).
27. Lymphocyte cell counts in middle age are positively associated with subsequent all-cause and cardiovascular mortality
28. PATH58 Kappa and lambda free light chains in CSF in the differential diagnosis of multiple sclerosis and its correlation with clinical subtypes
29. Eccentric exercise as an adjuvant to hepatitis B and meningitis ACWY vaccinations
30. Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance
31. Evaluating the effects of zoledronic acid (ZOL) on overall survival (OS) in patients (Pts) with multiple myeloma (MM): Results of the Medical Research Council (MRC) Myeloma IX study.
32. Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes
33. A162 Changes in M-Protein at Multiple Myeloma Relapse
34. B073 Quantification of IgAK/IgAL in Monoclonal Gammopathies
35. A177 Multiple Myeloma with Monoclonal Free IgG3 Heavy Chains and Free Kappa Light Chains
36. B596 Immunoglobulin Ratios: An Alternative to Immunofixation
37. Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ12,14,PGJ2
38. PSY10 A NOVEL APPROACHTO ADJUST FOR THE IMPACT ON SURVIVAL RESULTING FROM PATIENT CROSS-OVER FROM CONTROLTO EXPERIMENTAL TREATMENT IN CLINICAL TRIALS
39. Effects of exercise and mental stress on the antibody response to vaccination: Evidence that acute stress improves vaccine efficacy in humans
40. The Histone Deacetylase Inhibitor Sodium Valproate Has In Vitro Anti-Neoplastic Activity Against Primary Multiple Myeloma Cells and Cell Lines Both Alone and in Combination with Velcade.
41. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
42. Effective therapeutic use of rituximab in refractory Wegener's granulomatosis
43. Effect of prolonged exercise and carbohydrate ingestion on type 1 and type 2 T lymphocyte distribution and intracellular cytokine production in humans
44. Serum free light chains for monitoring multiple myeloma
45. Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease
46. Expression of CD4+/CD25+Treg(T-regulatory) cells is increased during normal pregnancy
47. An unrelated cytogenetic karyotype and intra-lineage shift at relapse of an aggressive paediatric B-precursor ALL
48. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytoplasmic antibody-positive patients
49. Steroid sulphatase activity is up-regulated during retinoid and vitamin D3-induced differentiation of HL60 cells
50. Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.